Patents by Inventor Swati Paliwal

Swati Paliwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mebeverine as soluble epoxide hydrolase inhibitor
    Patent number: 11766419
    Abstract: The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: September 26, 2023
    Assignee: Banasthali Vidyapith
    Inventors: Sarvesh Paliwal, Swapnil Sharma, Neetika Tripathi, Kanika Verma, Swati Paliwal
  • Mebeverine as soluble epoxy hydrolase inhibitor
    Publication number: 20220218648
    Abstract: The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 14, 2022
    Applicant: Banasthali Vidyapith
    Inventors: Sarvesh Paliwal, Swapnil Sharma, Neetika Tripathi, Kanika Verma, Swati Paliwal